BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4

  July 7, 2026

   · 

  1 min read
• 

  Obesity

  Hengrui, Kailera’s oral GLP-1 clears late-stage bar in China but US results still pending

  New data on Hengrui Pharma and Kailera Therapeutics’ investigational oral GLP-1 have validated the late-stage weight loss asset and paved the road for a regulatory submission in China, but analysts pointed to high rates of nausea and vomiting that could challenge the ongoing U.S. study.

  July 7, 2026

   · 

  4 min read

   · 

  Gabrielle Masson
• Press Releases

  Catalyst MedTech Announces Channel Partnership with APQ Health to Expand Access to Advanced Cardiac CT Analysis

  July 7, 2026

   · 

  4 min read
• Press Releases

  ADLM welcomes Dr. H. Timothy Hsiao as chief scientific officer

  July 7, 2026

   · 

  3 min read
• Press Releases

  Ipsen - Half year statement - 2026 06 30

  July 7, 2026

   · 

  5 min read
• Press Releases

  Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy

  July 7, 2026

   · 

  13 min read
• Press Releases

  Spear Bio to Unveil Novel Alzheimer’s Disease Immunoassays and Fully Automated Instrument Platform at AAIC 2026

  July 7, 2026

   · 

  4 min read
• Press Releases

  Eradivir Doses First Influenza Patient With EV25 in Bangladesh Study

  July 7, 2026

   · 

  3 min read
• 

  Approvals

  Vera moves into growing kidney disease space with FDA’s accelerated IgAN nod

  Vera Therapeutics’ atacicept, to be marketed as Trutakna, will go up against Novartis, Otsuka and possibly Vertex in the kidney disease primary IgA nephropathy after receiving an accelerated FDA approval.

  July 7, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Invictus Pharmacy and Mullan Pharmaceutical Inc. Announce Strategic Partnership to Expand Patient Access to FDA-Approved Ganirelix Acetate Injection Through Invictus Pharmacy

  July 7, 2026

   · 

  7 min read